Bioequivalence Study of CJ-30061 in Healthy Male Volunteers
NCT03657472
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Hyperlipidemia
Interventions
DRUG:
CJ-30061
DRUG:
Exforge® 5/160mg & Lipitor® 20mg
Sponsor
HK inno.N Corporation